Aytu Biopharma (AYTU) Assets Average (2011 - 2026)
Aytu Biopharma (AYTU) posted quarterly Assets Average of $116.8 million for Q1 2026, down 2.8% year-over-year from $120.2 million in Q1 2025, and down 5.38% quarter-over-quarter from $123.5 million in Q4 2025.
Aytu Biopharma (AYTU) Assets Average (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Assets Average for 16 consecutive years, with $116.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 2.8% year-over-year to $116.8 million; the TTM figure through Mar 2026 stood at $116.8 million (down 2.8% YoY), while the FY2025 annual figure was $121.1 million, down 4.83% from the prior year.
- Assets Average eased to $116.8 million in Q1 2026 per AYTU's latest filing, from $123.5 million in the prior quarter.
- Across five years, Assets Average topped out at $196.3 million in Q1 2022 and bottomed at $116.0 million in Q4 2024.
- Historically, Assets Average has averaged $134.6 million across 5 years, with a median of $130.1 million in 2024.
- On a YoY basis, Assets Average climbed as much as 135.27% in 2022 and fell as far as 41.71% in 2022.
- Aytu Biopharma's Assets Average stood at $145.7 million in 2022, then dropped by 9.37% to $132.1 million in 2023, then decreased by 12.14% to $116.0 million in 2024, then gained by 6.43% to $123.5 million in 2025, then decreased by 5.38% to $116.8 million in 2026.
- Business Quant data shows AYTU's Assets Average at $116.8 million in Q1 2026, $123.5 million in Q4 2025, and $124.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Aytu Biopharma | 24.81 Mn | -1.91 Mn | 7.60 Mn | 116.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.84 Mn |
| Dec 31, 2025 | 123.49 Mn |
| Sep 30, 2025 | 124.58 Mn |
| Jun 30, 2025 | 124.19 Mn |
| Mar 31, 2025 | 120.21 Mn |
| Dec 31, 2024 | 116.03 Mn |
| Sep 30, 2024 | 116.96 Mn |
| Jun 30, 2024 | 123.48 Mn |
| Mar 31, 2024 | 130.06 Mn |
| Dec 31, 2023 | 132.07 Mn |
| Sep 30, 2023 | 134.68 Mn |
| Jun 30, 2023 | 141.84 Mn |
| Mar 31, 2023 | 144.33 Mn |
| Dec 31, 2022 | 145.72 Mn |
| Sep 30, 2022 | 143.81 Mn |
| Jun 30, 2022 | 153.22 Mn |
| Mar 31, 2022 | 196.33 Mn |
| Dec 31, 2021 | 225.78 Mn |
| Sep 30, 2021 | 246.70 Mn |
| Jun 30, 2021 | 132.91 Mn |